Octave Bioscience

is a clinical decision support platform for multiple sclerosis. The platform leverages biomarker, imaging, and patient data to help guide treatment plans and drug selection. The Company has developed novel measurement tools that feed into structured analytical data models, leading to improved decision-making, better outcomes, and lower costs.